2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,b'EPS growth qtr over qtr more than 25%\n$JEF\n$HARP\n$LMAT\n$WGO\n$WY\n$PWFL\n$EGOV\n$LAND\n$MSN\n$MLAB\n$KLIC\n$QFIN\n$AEM\n$AYX\n$GPN\n$ALLT\n$TELA\n$BX\n$DMS\n$RGNX\n$LEAF\n$TMHC\n$UFPI\n$AGX\n$CYBE\n$SLGG\n$VLRS\n$ASND\n$DLR\n$ACLS\n$PCH\n$SNEX\n$LOV\n$LTRX\n$EVA\n$BRBR\n$ABBV\n$CYD\n$MDWD\n$LCII\n$HELE\n$SBBP\n$LH'
2021-01-03,"b'$RGNX $45.36 -1.39  -2.97%RGX-121 MPS IIPhase 1/2 02/08/2021 Phase 1/2 initial data released December 9, 2020 - well-tolerated with no drug-related serious adverse events (SAEs). Additional data due at WORLDSymposium February 8 - 12, 2021. Cohort 3 to commence enrollment 1Q 21.'"
2021-01-03,"b""I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the changes at the end of each week in 21'. $VRTX $SRPT $EXAS $CRSP $RARE $ARWR $BBIO $RCKT $EDIT $BLUE $SGMO $QURE $RGNX $FLGT $ZIOP $VYGR $SIOX $ABEO https://t.co/I0ROS0RjAq"""
2021-01-03,b'RT @MaisaCorp: #Biotech companies to be acquired?\n\n$88.85 : $BMRN BioMarin Pharmaceutical\n$54.86 : $DCPH Deciphera Pharmaceuticals\n$45.95 :\xe2\x80\xa6'
2021-01-03,b'Following negotiations in NYC $ASDN BOD set to vote on buyout deal as early as this weekend\nhttps://t.co/fK8PPZ6hwp\n\n$ECPG $MLNX $SHOS $RGNX $HTHT $PRHL $TDS $BGNE $DPLO $INN $NJR $BKNG'
2021-01-02,b'RT @EmergingGrowth1: $RSPI RespireRx Pharmaceuticals Inc. (RSPI) Announces $2 Million Funding Commitment\n\nhttps://t.co/Ba6Iukhqzq\n\n$CYDY $A\xe2\x80\xa6'
2021-01-02,b'RT @mediasentiment: $RGNX  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 89'
2021-01-02,b'$RGNX  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 89'
2021-01-02,"b'$RGNX in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on December 22, 2020. View odds for this and other indicators: https://t.co/7ghJcKm9Kz #Regenxbio #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/C7iTlvt2bi'"
2021-01-01,"b'@semodough $clsd, $rgnx I feel have potential in the ophthalmology space'"
2021-01-01,"b'$RGNX in Uptrend: 50-day Moving Average broke above 200-day Moving Average on December 21, 2020. View odds for this and other indicators: https://t.co/oHEMKwiRIV #Regenxbio #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Mmmt1XVABx'"
2020-12-31,b'2/ Clean safety on first patients according to $RGNX q3 earnings call. Should get 6 month data in late February/March. No inflammation bodes well for transduction'
2020-12-31,b'Bruch\xe2\x80\x99s Membrane is the barrier to suprachoroidal delivery that led $JNJ to buy an intravitreal delivered Geographic atrophy company over $CLSD or $RGNX'
2020-12-31,"b""RT @Ruven27: @PersimmonTI $CLSD has upside in it's partnership pipeline. RGX-314 w/ $RGNX Ph2 data due early in Q1'21.  \n\nDeal 09/2019:  RG\xe2\x80\xa6"""
2020-12-31,"b""@PersimmonTI $CLSD has upside in it's partnership pipeline. RGX-314 w/ $RGNX Ph2 data due early in Q1'21.  \n\nDeal 09/2019:  RGNX would pay CLSD also pre-revenue, an undisclosed amount, plus up to $34M in development milestones, $102M in sales milestones + other royalties on net sales."""
2020-12-30,"b""$RGNX:\n\nNew Insider Filing on REGENXBIO Inc.'s\n\nPresident and CEO\n\nKENNETH T. MILLS:\n\nhttps://t.co/4wsRkLn1a2"""
2020-12-30,b'RT @biostonks: Gene tx players 1-10B mkt cap $NTRA $NVTA $ARWR $FATE $BBIO $IOVA $EDIT $PTCT $PACB $ALLO $NTLA $CDNA $ALKS $RCKT $NSTG $BLU\xe2\x80\xa6'
2020-12-30,"b'#FWSells $RGNX Mills Kenneth T., President and CEO of REGENXBIO Inc. sold 6,500 shares on 2020-12-28. https://t.co/Zh0Qf7JBDB'"
2020-12-30,b'Gene tx players 1-10B mkt cap $NTRA $NVTA $ARWR $FATE $BBIO $IOVA $EDIT $PTCT $PACB $ALLO $NTLA $CDNA $ALKS $RCKT $NSTG $BLUE $AGIO $ARCT $SGMO $SRNE $PGEN $RGNX $QURE $DRNA $MYGN $ADVM $FLGT $CLLS $KRYS $PASG\nfeel free to give input https://t.co/ln7esOVk86'
2020-12-30,"b""RT @JamesEKrause: @XBIObserver @ohmsonite $REGN $OCUL $KOD $RGNX $APLS $ANNX #NVS and more...\n\n&lt;It's really something to see the grand visi\xe2\x80\xa6"""
2020-12-29,"b""@XBIObserver @ohmsonite $REGN $OCUL $KOD $RGNX $APLS $ANNX #NVS and more...\n\n&lt;It's really something to see the grand vision&gt;\n\nWhether the double pun was intended or not, one major learning here was to invest in #ophthalmology companies. I have my eyes wide open."""
2020-12-29,b'RT @askwarrenhq: $IRNC Confirmation Of Buyout Offer On The Table Following Talks In Delaware\nhttps://t.co/Mv3xmUJu9A\n\n$ECPG $MLNX $SHOS $RG\xe2\x80\xa6'
2020-12-29,b'RT @Brady_Atlas: Gene Therapy $REGN $CRSP $BMRN $BLUE $RGNX $VRTX $BLUE $ARKG Early stages of compiling names on this but another big theme\xe2\x80\xa6'
2020-12-29,b'RT @Brady_Atlas: Gene Therapy $REGN $CRSP $BMRN $BLUE $RGNX $VRTX $BLUE $ARKG Early stages of compiling names on this but another big theme\xe2\x80\xa6'
2020-12-29,b'RT @Brady_Atlas: Gene Therapy $REGN $CRSP $BMRN $BLUE $RGNX $VRTX $BLUE $ARKG Early stages of compiling names on this but another big theme\xe2\x80\xa6'
2020-12-29,b'RT @Brady_Atlas: Gene Therapy $REGN $CRSP $BMRN $BLUE $RGNX $VRTX $BLUE $ARKG Early stages of compiling names on this but another big theme\xe2\x80\xa6'
2020-12-29,"b'Gene Therapy $REGN $CRSP $BMRN $BLUE $RGNX $VRTX $BLUE $ARKG Early stages of compiling names on this but another big theme in 2021. As was the case with prior sector posts, looking for dips on any of these major themes post market correction to load, will post charts when ready.'"
2020-12-28,"b""Some PT's..\n\n$AMZN reit OW, $2100 Piper\n$ALNY 210\xe2\x9e\x9c230 FBR\n$ANDV 148\xe2\x9e\x9c152 JPM\n$DLR 128\xe2\x9e\x9c131 RBC\n$ESTA init.\nBuy $35 Jeff\nOP $35 Cowen\n$MYL 42\xe2\x9e\x9c51 RBC\n$PLNT 40\xe2\x9e\x9c45 Imperial Cap\n$PZZA u/g $52 Longbow\n$RGNX 48\xe2\x9e\x9c83 Barclays\n$RUBY init.\nBuy $40 Jeff\nOW $37 MS\n$TLRY init. OP, $34 Cowen"""
2020-12-28,"b""$RGNX:\n\nNew Insider Filing on REGENXBIO Inc.'s\n\nChief Financial Officer\n\nVITTAL VASISTA:\n\nhttps://t.co/2viTjTSdiK"""
2020-12-28,"b""$RGNX:\n\nNew Insider Filing on REGENXBIO Inc.'s\n\nPresident and CEO\n\nKENNETH T. MILLS:\n\nhttps://t.co/KzUc5ur0Mo"""
2020-12-28,"b'Stocks in Insider Selling today: $RGNX, Current Price: $47.94, Change today: -1.68%, Total Traded Volume: 266,521 https://t.co/vokfBxGkWG'"
2020-12-28,"b'Vittal Vasista, Chief Financial Officer of REGENXBIO INC. - $RGNX sold 24500 shares to now own a total of 133024, anomalous of their normal trading pattern.\n\nhttps://t.co/xs3v61ehfd'"
2020-12-28,"b'Insider Vittal Vasista reports selling 24,500 shares of $RGNX for a total cost of $1,225,211.24 https://t.co/71cfN6q3bF'"
2020-12-28,"b'An executive and/or major shareholder of $RGNX (REGENXBIO Inc.) reportedly sold ~$ 1,225,211 worth of shares\n\n\xe2\x9e\xa1\xef\xb8\x8f https://t.co/EUocy7ZmFg \xe2\xac\x85\xef\xb8\x8f\n\n #stock2020'"
2020-12-28,"b'#FWSells $RGNX Vasista Vittal, Chief Financial Officer of REGENXBIO Inc. sold 24,500 shares on 2020-12-24. https://t.co/Zh0Qf7JBDB'"
2020-12-28,"b'#FWSells $RGNX Mills Kenneth T., President and CEO of REGENXBIO Inc. sold 4,500 shares on 2020-12-23. https://t.co/Zh0Qf7JBDB'"
2020-12-28,"b""RT @ebcapital: Here are some of the #biotech stocks I'm \xf0\x9f\x91\x80 b/c 2021 catalysts (data/PDUFA/comm'l): \n\n$SWTX\n$TPTX\n$IOVA\n$RGNX\n$YMAB\n$BLUE"""
2020-12-28,"b""RT @ebcapital: Here are some of the #biotech stocks I'm \xf0\x9f\x91\x80 b/c 2021 catalysts (data/PDUFA/comm'l): \n\n$SWTX\n$TPTX\n$IOVA\n$RGNX\n$YMAB\n$BLUE"""
2020-12-28,"b""RT @ebcapital: Here are some of the #biotech stocks I'm \xf0\x9f\x91\x80 b/c 2021 catalysts (data/PDUFA/comm'l): \n\n$SWTX\n$TPTX\n$IOVA\n$RGNX\n$YMAB\n$BLUE"""
2020-12-28,"b""Here are some of the #biotech stocks I'm \xf0\x9f\x91\x80 b/c 2021 catalysts (data/PDUFA/comm'l): \n\n$SWTX\n$TPTX\n$IOVA\n$RGNX\n$YMAB\n$BLUE"""
2020-12-27,"b""Your uncle's old Atari told me to stop buying REGENXBIO Inc. $RGNX #FreeTip"""
2021-01-08,b'RT @Bios_n_Techs: $RGNX Regenxbio Prices Public Offering of 4.3M Shares at $47/Shr'
2021-01-08,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith\n- Sorted by % Volume Increase [+101] \n\nA key part of our process in identi\xe2\x80\xa6'
2021-01-08,b'$RGNX Regenxbio Prices Public Offering of 4.3M Shares at $47/Shr'
2021-01-08,"b'$RGNX [15s. delayed]: Issued Press Release on January 08, 07:05:00: REGENXBIO Announces Pricing Of Public Offering Of Common Stock https://t.co/xk0G9jPMer'"
2021-01-08,b'REGENXBIO Announces Pricing Of Public Offering Of Common Stock $RGNX https://t.co/y52LSllQWo'
2021-01-08,b'$RGNX NEW ARTICLE : REGENXBIO Announces Pricing Of Public Offering Of Common Stock https://t.co/DCBxiaEalr Get all the latest $RGNX related news here : https://t.co/bw71PuuoPF https://t.co/dBKnFUwEBJ'
2021-01-08,b'$RGNX  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 373'
2021-01-08,b'REGENXBIO prices upsized stock offering at $47 $RGNX https://t.co/SCJdTHq8aA'
2021-01-08,b'$RGNX - REGENXBIO prices upsized stock offering at $47 https://t.co/AH59LqxFSs'
2021-01-08,b'Regenxbio 4.26M share Secondary priced at $47.00\n$RGNX'
2021-01-08,b'$RGNX\nREGENXBIO Announces Pricing Of Public Offering Of Common Stock'
2021-01-08,b'$RGNX prices 47'
2021-01-08,b'$RGNX prices offering. 4.26M shares at $47'
2021-01-08,b'$RGNX REGENXBIO Announces Pricing Of Public Offering Of Common Stock\nhttps://t.co/KKHZDASrmk\n\n#offering'
2021-01-08,"b""1-8-21\nIpo's \n$CGEM priced 10mm at 21 (heavily oversubscribed priced above range and increased shares)\n$GRCL increased size to 11mm ( Mult times oversubscribed)\nOfferings \n$BLNK 5mm, $RGNX $175mm \nAnnounced late\n$BNGO , $CERC \nhttps://t.co/NcgMalff9X \n@AjTrader7 @JT_IPOSquawk"""
2021-01-08,b'$RGNX showing signs of big buying off the lows. Would have preferred to see this pull back consolidate a bit more and tighten up we will take what we can get. Watch over $50.15. https://t.co/4i3iXsXysv'
2021-01-08,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith\n- Sorted by % Volume Increase [+101] \n\nA key part of our process in identi\xe2\x80\xa6'
2021-01-07,"b'@sciencescanner @adamfeuerstein @biotechinvstr @Biohazard3737 Interestingly enough, $RGNX just announced this very week their own new preclinical candidate for #DMD.'"
2021-01-07,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith\n- Sorted by % Volume Increase [+101] \n\nA key part of our process in identi\xe2\x80\xa6'
2021-01-07,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith\n- Sorted by % Volume Increase [+101] \n\nA key part of our process in identi\xe2\x80\xa6'
2021-01-07,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith\n- Sorted by % Volume Increase [+101] \n\nA key part of our process in identi\xe2\x80\xa6'
2021-01-07,b'RT @TraderLion_: Daily Up on Volume scan powered by @MarketSmith\n- Sorted by % Volume Increase [+101] \n\nA key part of our process in identi\xe2\x80\xa6'
2021-01-07,"b'Daily Up on Volume scan powered by @MarketSmith\n- Sorted by % Volume Increase [+101] \n\nA key part of our process in identifying emerging themes, gauging risk appetite, and generating ideas.\n\nStandouts\n$DMTK\n$SNOW\n$REAL\n$CRSP\n$PLUG\n$TXG\n$RGNX\n$DM\n\n#IBDPartner https://t.co/AOja2BeUq3'"
2021-01-07,"b""$RGNX:\n\nNew Insider Filing on REGENXBIO Inc.'s\n\nPresident and CEO\n\nKENNETH T. MILLS:\n\nhttps://t.co/4vweKyTlrY"""
2021-01-07,"b'RT @chunfeng0808: Next generation biotech platform leader:\n1) B-Bio-database: $ILMN, $TXG $TWST 13andme; $ADPT\n2) Gene edit: $CRSP $BEAM, $\xe2\x80\xa6'"
2021-01-07,"b'Next generation biotech platform leader:\n1) B-Bio-database: $ILMN, $TXG $TWST 13andme; $ADPT\n2) Gene edit: $CRSP $BEAM, $EDIT, $NTLA\n3) mRNA and siRNA: $mRNA, $BNTX,$CVAC, $TBIO, $ARWR, $ALNY\n4) Gene therapy: $FOLD, $RGNX, $GBIO;'"
2021-01-07,"b'RT @EmergingGrowth1: $CYDY CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, &amp; High Likelihood of Approval\n\nhttps\xe2\x80\xa6'"
2021-01-07,b'3 Top Small-Cap Stocks to Buy in January @themotleyfool #stocks $KOP $RGNX $ZYXI https://t.co/X1haFip1x5'
2021-01-07,"b'RT @EmergingGrowth1: $CYDY CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, &amp; High Likelihood of Approval\n\nhttps\xe2\x80\xa6'"
2021-01-07,"b'RT @EmergingGrowth1: $CYDY CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, &amp; High Likelihood of Approval\n\nhttps\xe2\x80\xa6'"
2021-01-07,"b'RT @EmergingGrowth1: $CYDY CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, &amp; High Likelihood of Approval\n\nhttps\xe2\x80\xa6'"
2021-01-07,b'$INN -3% (launches convertible notes offering) \n\n$RGNX -2.4% (stock offering) \n\n$BLNK -1.9% (files for 5 mln share offering; also files for mixed securities shelf offering)'
2021-01-07,"b'RT @EmergingGrowth1: $CYDY CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, &amp; High Likelihood of Approval\n\nhttps\xe2\x80\xa6'"
2021-01-07,"b'$CYDY CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, &amp; High Likelihood of Approval\n\nhttps://t.co/vuSfJEwxR2\n\n$AZN $BBIO $PFE $RHHBY $CANF $EPIX $MRK $GNCA $SYBX $XYN $REGN $RGNX $BMY $LLY $ABT\n\n#CoronaVirus #Covid19 #Vaccine #HotStocks #StockMarket'"
2021-01-07,b'$RGNX (-0.1% pre) Regenxbio (RGNX) Announces Proposed $175M Public Offering Of Common Stock - SI\n\nhttps://t.co/DWmDbp1oO1'
2021-01-07,b'$RGNX Raymond James Outperform&gt;&gt;Strong Buy $60 \n$RRGB Raymond James Mkt Perform&gt;&gt;Outperform $26 \n$SUM Stephens Equal-Weight&gt;&gt;Overweight \n$TU Canaccord Genuity Hold&gt;&gt;Buy \n$VMC Stephens Equal-Weight&gt;&gt;Overweight \n$WEX Wolfe Research Peer Perform&gt;&gt;Outperform'
2021-01-07,b'$RGNX  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 249'
2021-01-07,"b'$RGNX in Downtrend: its price may drop because broke its higher Bollinger Band on December 22, 2020. View odds for this and other indicators: https://t.co/BkSlWpssgD #Regenxbio #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/cRhNVbiwOs'"
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,"b""$RGNX:\n\nNew Insider Filing on REGENXBIO Inc.'s\n\nChief Medical Officer\n\nSTEVE PAKOLA:\n\nhttps://t.co/xWcptOoJ5f"""
2021-01-07,"b'$RGNX (47ah) Good time for a secondary, given recent run-up.'"
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'RT @PatternProfits: Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong\xe2\x80\xa6'
2021-01-07,b'Daily Velocity Scan for 1/6. 251 names (+858). $ONTO follows through nicely on 3 weeks tight pattern. $VFF $TPB strong 21ema support bounces. Biotech back in a big way as flags b/o; $DMTK $RDUS $NTLA $FATE $RGNX. Solar hot again too. Personal screen generated through @MarketSmith https://t.co/7ovWHjdFpX'
2021-01-07,b'REGENXBIO Announces Proposed Public Offering Of Common Stock $RGNX https://t.co/7LjIYqUWLa'
2021-01-07,b'Top 15 Pharmaceuticals stocks with market cap over 1 billion today. \n\nhttps://t.co/hVOwcz0PBt\n\n$FATE $KURA $NTLA $RGNX $EPZM $RYTM $CYTK $ALGS $MYGN $MRNA $NVAX $XNCR $FOLD $TBIO $REPL\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/iGugDaj75m'
2021-01-07,b'REGENXBIO readies common stock public offering $RGNX https://t.co/OlfoOOE9F5'
2021-01-07,"b""$RGNX:\n\nNew Insider Filing on REGENXBIO Inc.'s\n\nChief Financial Officer\n\nVITTAL VASISTA:\n\nhttps://t.co/2716qmaSOf"""
2021-01-06,"b""$RGNX:\n\nNew Insider Filing on REGENXBIO Inc.'s\n\nChief Oper. &amp; Tech. Officer\n\nCURRAN SIMPSON:\n\nhttps://t.co/ch2Oo1Qeld"""
2021-01-06,b'Biopharma Daily Stock Updates - 01/06/20\n$XBI $143.32 (+2.04%) \xf0\x9f\x93\x88\n\nPIPELINE:\n$IMRA (-37.97%) - Ph 2a Results\n$RDHL (-3.76%) - Fast Track\n$RDUS (+15.76%) - Acquisition\n$SELB (+8.22%)  - Data\n$ZNTL (-6.54%) - Initiation\n\nFINANCE:\n$RGNX (+8.39%) - Offering\n\nhttps://t.co/kM84hB4YrB'
